Cargando…

A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction

BACKGROUND: With the rapid development of sequencing technologies, collecting diverse types of cancer omics data become more cost-effective. Many computational methods attempted to represent and fuse multiple omics into a comprehensive view of cancer. However, different types of omics are related an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Kaiwen, Huang, Weixian, Hu, Jinlong, Dong, Shoubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477832/
https://www.ncbi.nlm.nih.gov/pubmed/32646413
http://dx.doi.org/10.1186/s12911-020-1114-3
_version_ 1783579965888921600
author Tan, Kaiwen
Huang, Weixian
Hu, Jinlong
Dong, Shoubin
author_facet Tan, Kaiwen
Huang, Weixian
Hu, Jinlong
Dong, Shoubin
author_sort Tan, Kaiwen
collection PubMed
description BACKGROUND: With the rapid development of sequencing technologies, collecting diverse types of cancer omics data become more cost-effective. Many computational methods attempted to represent and fuse multiple omics into a comprehensive view of cancer. However, different types of omics are related and heterogeneous. Most of the existing methods do not consider the difference between omics, so the biological knowledge of individual omics may not be fully excavated. And for a given task (e.g. predicting overall survival), these methods prefer to use sample similarity or domain knowledge to learn a more reasonable representation of omics, but it’s not enough. METHODS: For the purpose of learning more useful representation for individual omics and fusing them to improve the prediction ability, we proposed an autoencoder-based method named MOSAE (Multi-omics Supervised Autoencoder). In our method, a specific autoencoder were designed for each omics according to their size of dimension to generate omics-specific representations. Then, a supervised autoencoder was constructed based on specific autoencoder by using labels to enforce each specific autoencoder to learn both omics-specific and task-specific representations. Finally, representations of different omics that generate from supervised autoencoders were fused in a traditional but powerful way, and the fused representation was used for subsequent predictive tasks. RESULTS: We applied our method over TCGA Pan-Cancer dataset to predict four different clinical outcome endpoints (OS, PFI, DFI, and DSS). Compared with traditional and state-of-the-art methods, MOSAE achieved better predictive performance. We also tested the effects of each improvement, which all have a positive effect on predictive performance. CONCLUSIONS: Predicting clinical outcome endpoints are very important for precision medicine and personalized medicine. And multi-omics fusion is an effective way to solve this problem. MOSAE is a powerful multi-omics fusion method, which can generate both omics-specific and task-specific representation for given endpoint predictive tasks and improve the predictive performance.
format Online
Article
Text
id pubmed-7477832
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74778322020-09-09 A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction Tan, Kaiwen Huang, Weixian Hu, Jinlong Dong, Shoubin BMC Med Inform Decis Mak Research BACKGROUND: With the rapid development of sequencing technologies, collecting diverse types of cancer omics data become more cost-effective. Many computational methods attempted to represent and fuse multiple omics into a comprehensive view of cancer. However, different types of omics are related and heterogeneous. Most of the existing methods do not consider the difference between omics, so the biological knowledge of individual omics may not be fully excavated. And for a given task (e.g. predicting overall survival), these methods prefer to use sample similarity or domain knowledge to learn a more reasonable representation of omics, but it’s not enough. METHODS: For the purpose of learning more useful representation for individual omics and fusing them to improve the prediction ability, we proposed an autoencoder-based method named MOSAE (Multi-omics Supervised Autoencoder). In our method, a specific autoencoder were designed for each omics according to their size of dimension to generate omics-specific representations. Then, a supervised autoencoder was constructed based on specific autoencoder by using labels to enforce each specific autoencoder to learn both omics-specific and task-specific representations. Finally, representations of different omics that generate from supervised autoencoders were fused in a traditional but powerful way, and the fused representation was used for subsequent predictive tasks. RESULTS: We applied our method over TCGA Pan-Cancer dataset to predict four different clinical outcome endpoints (OS, PFI, DFI, and DSS). Compared with traditional and state-of-the-art methods, MOSAE achieved better predictive performance. We also tested the effects of each improvement, which all have a positive effect on predictive performance. CONCLUSIONS: Predicting clinical outcome endpoints are very important for precision medicine and personalized medicine. And multi-omics fusion is an effective way to solve this problem. MOSAE is a powerful multi-omics fusion method, which can generate both omics-specific and task-specific representation for given endpoint predictive tasks and improve the predictive performance. BioMed Central 2020-07-09 /pmc/articles/PMC7477832/ /pubmed/32646413 http://dx.doi.org/10.1186/s12911-020-1114-3 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tan, Kaiwen
Huang, Weixian
Hu, Jinlong
Dong, Shoubin
A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
title A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
title_full A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
title_fullStr A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
title_full_unstemmed A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
title_short A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
title_sort multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477832/
https://www.ncbi.nlm.nih.gov/pubmed/32646413
http://dx.doi.org/10.1186/s12911-020-1114-3
work_keys_str_mv AT tankaiwen amultiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction
AT huangweixian amultiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction
AT hujinlong amultiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction
AT dongshoubin amultiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction
AT tankaiwen multiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction
AT huangweixian multiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction
AT hujinlong multiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction
AT dongshoubin multiomicssupervisedautoencoderforpancancerclinicaloutcomeendpointsprediction